tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
charlatan vs DoseFinding
A side-by-side editorial comparison of charlatan and DoseFinding — release velocity, themes, recent moves, and the top alternatives to consider.
charlatan vs DoseFinding: at a glance
What is charlatan?
R's fake-data generator rebuilt its provider hierarchy so contributors can add one locale without touching the rest.
charlatan generates realistic fake data — names, addresses, phone numbers, jobs, internet artefacts — across many locales, following the same model as faker in Python and Perl. The 0.6.1 release reworked the provider class hierarchy so locale-specific providers inherit from a parent, and 0.6.2 since has been a documentation rebuild that happened to surface a duplicate Norwegian phone number pattern. Activity is sparse and bursty.
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
charlatan vs DoseFinding: editorial side-by-side
charlatan
0.0ANALYTICS
R's fake-data generator rebuilt its provider hierarchy so contributors can add one locale without touching the rest.
◆ Current state
charlatan generates realistic fake data — names, addresses, phone numbers, jobs, internet artefacts — across many locales, following the same model as faker in Python and Perl. The 0.6.1 release reworked the provider class hierarchy so locale-specific providers inherit from a parent, and 0.6.2 since has been a documentation rebuild that happened to surface a duplicate Norwegian phone number pattern. Activity is sparse and bursty.
◆ Where it's heading
The package's value scales with locale coverage, and its releases track that: early versions added data-type providers, middle versions added locales one contributor at a time, and 0.6.1 attacked the bottleneck by restructuring the class hierarchy so a locale can override a single function. Development has effectively been handed to contributors, with maintainer releases reduced to docs rebuilds and CRAN compliance.
◆ Prediction
Expect the next substantive release to be an accumulation of contributed locales and providers arriving through the new parent-provider structure, rather than maintainer-driven feature work.
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Alternatives to charlatan and DoseFinding
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either charlatan or DoseFinding.
Tplyr
Tplyr made clinical summary tables explain where every number came from.
rlistings
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all charlatan alternatives → · See all DoseFinding alternatives →
Recent activity from charlatan and DoseFinding
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 7mo agocharlatanDocs rebuild surfaces a duplicate Norwegian phone pattern
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agocharlatanProvider classes restructured so locales can override single functions ⚡
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
- 6y agocharlatanNew locales and providers; allowed_locales() added
- 7y agocharlatanLocale naming standardised; French and Danish data corrected
- 8y agocharlatancharlatan v0.2.2
- 8y agocharlatanSix new providers broaden charlatan beyond names and addresses
Frequently asked questions
What is the difference between charlatan and DoseFinding?
They serve adjacent needs but don't currently overlap on shipped themes. charlatan and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is charlatan better than DoseFinding?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. charlatan and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to charlatan?
Top charlatan alternatives in Analytics are ranked by recent ship velocity. Browse the "charlatan alternatives" section above for the current picks, or visit /alternatives/charlatan for the full list with editorial commentary on each.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.